MNIVF (Monash IVF Group) 3-Month Share Buyback Ratio: 0.00% (As of Dec. 2025 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MNIVF Monash IVF Group Ltd MNIVF
78 GF Score
Price $0.40
GF Value $0.85
! 7 Warning Signs
View Full Analysis

What is Monash IVF Group 3-Month Share Buyback Ratio?

Monash IVF Group MNIVF 78 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus rates MNIVF with a GF Score™ of 78/100 and a GF Value™ of $0.85. The stock has 7 warning signs investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

MNIVF
78GF Score
Monash IVF Group Ltd MNIVF
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
Monash IVF Group (MNIVF) has a 3-Month Share Buyback Ratio of 0.00 as of Dec. 2025. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Monash IVF Group and its competitors.
Is Monash IVF Group's 3-Month Share Buyback Ratio too high?
Monash IVF Group's current 3-Month Share Buyback Ratio is 0.00. Overall, Monash IVF Group has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Monash IVF Group's 3-Month Share Buyback Ratio compare to TMO and DHR?
Monash IVF Group's 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Medical Diagnostics & Research company?
A good 3-Month Share Buyback Ratio depends on the Medical Diagnostics & Research industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Monash IVF Group and its competitors. Monash IVF Group's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monash IVF Group stock overvalued right now?
Monash IVF Group (MNIVF) has a current 3-Month Share Buyback Ratio of 0.00. The stock's GF Value™ is $0.85, compared to a current price of $0.40 — trading 52.9% below its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. Monash IVF Group's overall GF Score™ is 78/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Monash IVF Group (MNIVF), the current 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Monash IVF Group (MNIVF) Overvalued in 2026?

Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued. The current stock price of $0.40 is trading 52.9% below its estimated GF Value™ of $0.85.

Key valuation signals for MNIVF:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: $0.85 vs. price of $0.40 (52.9% below fair value)
  • GF Score™: 78/100 with 7 warning signs

No single metric tells the full story. See the MNIVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Monash IVF Group Business Description

Other Exchanges MVF:Australia
Address 510 Church Street, Level 1, Cremorne, VIC, AUS, 3121
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
78GF Score

Get the complete analysis for MNIVF

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price
$0.85
GF Value